Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
42.56
-1.09 (-2.50%)
Nov 21, 2024, 4:00 PM EST - Market closed
Avidity Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -280.49 | -212.22 | -174 | -118.01 | -44.36 | -24.73 | Upgrade
|
| Depreciation & Amortization | 2.65 | 2.1 | 1.39 | 0.64 | 0.37 | 0.35 | Upgrade
|
| Other Amortization | - | - | - | - | - | 0.07 | Upgrade
|
| Loss (Gain) From Sale of Investments | -17.52 | -11.27 | -0.62 | 0.18 | 0.01 | - | Upgrade
|
| Stock-Based Compensation | 47.06 | 38.22 | 27.14 | 17.06 | 4.31 | 0.41 | Upgrade
|
| Other Operating Activities | 3.3 | 2.98 | 2.75 | 0.68 | 0.21 | 7.04 | Upgrade
|
| Change in Accounts Payable | 17.08 | 1.77 | 18.32 | 6.04 | 5.75 | 0.44 | Upgrade
|
| Change in Unearned Revenue | 59.95 | 62.99 | -5.12 | -4.44 | -3.1 | 18.94 | Upgrade
|
| Change in Other Net Operating Assets | -16.53 | -3.63 | -6.13 | 3.04 | -0.32 | -0.02 | Upgrade
|
| Operating Cash Flow | -184.5 | -119.06 | -136.27 | -94.81 | -37.12 | 2.49 | Upgrade
|
| Capital Expenditures | -4.01 | -4.23 | -2.82 | -3.74 | -1.09 | -0.24 | Upgrade
|
| Investment in Securities | -734.98 | -125.84 | -187.13 | -78.78 | -6.69 | - | Upgrade
|
| Investing Cash Flow | -738.99 | -130.07 | -189.96 | -82.52 | -7.79 | -0.24 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 19.45 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -4.68 | -2.8 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | -4.68 | 16.65 | Upgrade
|
| Issuance of Common Stock | 1,069 | 93.86 | 346.17 | 176.32 | 274.52 | 0.07 | Upgrade
|
| Preferred Dividends Paid | - | - | - | - | - | -0.11 | Upgrade
|
| Dividends Paid | - | - | - | - | - | -0.11 | Upgrade
|
| Financing Cash Flow | 1,211 | 93.86 | 346.17 | 176.32 | 272.04 | 89.23 | Upgrade
|
| Net Cash Flow | 287.04 | -155.27 | 19.95 | -1.01 | 227.14 | 91.49 | Upgrade
|
| Free Cash Flow | -188.51 | -123.29 | -139.09 | -98.55 | -38.21 | 2.26 | Upgrade
|
| Free Cash Flow Margin | -1863.31% | -1289.67% | -1507.92% | -1056.76% | -562.97% | 97.24% | Upgrade
|
| Free Cash Flow Per Share | -1.91 | -1.69 | -2.67 | -2.38 | -1.76 | 0.83 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.57 | 0.32 | Upgrade
|
| Levered Free Cash Flow | -135.19 | -86.66 | -71.82 | -48.59 | -19.53 | -10.21 | Upgrade
|
| Unlevered Free Cash Flow | -135.19 | -86.66 | -71.82 | -48.59 | -19.4 | -5.67 | Upgrade
|
| Change in Net Working Capital | -22.05 | -24.5 | -14.3 | -11.24 | -4.69 | -4.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.